Research Topics
| Paul J ScheelSummaryAffiliation: Johns Hopkins University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosisPaul J Scheel
Division of Nephrology, Department of Medicine, The Johns Hopkins Medical Institution, Baltimore, Maryland 21205, USA
J Urol 178:140-3; discussion 143-4. 2007..We determined the efficacy of a combination of corticosteroids and mycophenolate mofetil for retroperitoneal fibrosis...
Retroperitoneal fibrosisPaul J Scheel
Division of Nephrology, The Johns Hopkins University School of Medicine, 1830 East Monument Street, Room 416, Baltimore, MD 21205, USA Electronic address
Rheum Dis Clin North Am 39:365-81. 2013..This review focuses on the recent advances in the classification, epidemiology, pathophysiology, pathology, imaging, and treatment of RPF...
Medical management of retroperitoneal fibrosisPaul J Scheel
Baltimore, MD
Trans Am Clin Climatol Assoc 123:283-91. 2012..Small series and case reports suggest that a combination of mycophenolate mofetil and prednisone is an efficatious and safe treatment for patients with retroperitoneal fibrosis...- Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case seriesPaul J Scheel
The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
Ann Intern Med 154:31-6. 2011..Small case series suggest that a combination of mycophenolate mofetil and prednisone may be an effective treatment for patients with retroperitoneal fibrosis... - Retroperitoneal fibrosis: the clinical, laboratory, and radiographic presentationPaul J Scheel
Division of Nephrology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
Medicine (Baltimore) 88:202-7. 2009..We attempt to solidify a proper scheme of classification for the disease, and suggest an anatomic classification system that may be used for future studies... - Observations on a cohort of HIV-infected patients undergoing native renal biopsyAdam R Berliner
Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
Am J Nephrol 28:478-86. 2008..This study aims to explore the spectrum of renal disease in HIV-infected patients, identify clinical predictors of HIV-associated nephropathy (HIVAN), and investigate the performance of renal biopsy in HIV-infected patients... - Cocaine use and hypertensive renal changes in HIV-infected individualsDerek M Fine
Department of Medicine, Johns Hopkins School of Medicine and the Johns Hopkins Hospital, Baltimore, Maryland, USA
Clin J Am Soc Nephrol 2:1125-30. 2007..This study was conducted to evaluate the possible association of cocaine use and histopathologic findings on biopsy in this population... - Mycophenolate mofetil treatment for primary glomerular diseasesMichael J Choi
Nephrology Division, Johns Hopkins University School of Medicine, 1830 E Monument Street, Baltimore, MD 21205 2196, USA
Kidney Int 61:1098-114. 2002..Treatment of primary glomerular diseases may be unsuccessful or have potential toxicities. Therefore, we evaluated the use of mycophenolate mofetil (MMF) for empirical treatment of primary glomerulopathies... - Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathyMohamed G Atta
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
Am J Med 118:1288. 2005.... - Influence of intravenous drug abuse on vascular access placement and survival in HIV-seropositive patientsJoseph A Eustace
Division of Nephrology, The Welch Center for Disease Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD, USA
Nephron Clin Pract 100:c38-45. 2005..The influence of intravenous drug abuse (IVDA) on hemodialysis access placement practices and access survival in HIV-infected patients is unknown... - Sonography as a predictor of human immunodeficiency virus-associated nephropathyMohamed G Atta
Department of Medicine, Division of Nephrology, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, Baltimore, Maryland 21205, USA
J Ultrasound Med 23:603-10; quiz 612-3. 2004..To determine whether renal sonography can be used to predict the pathologic diagnosis of human immunodeficiency virus-associated nephropathy... - Renal artery stenosis by three-dimensional magnetic resonance angiography in type 2 diabetics with uncontrolled hypertension and chronic renal insufficiency: prevalence and effect on renal functionDonna I Myers
Johns Hopkins University School of Medicine, Baltimore, MD, USA
Am J Kidney Dis 41:351-9. 2003..The variable course of renal disease in type 2 diabetes mellitus in part may reflect associated atherosclerotic nephropathy... - HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patientsMichelle Estrella
Department of Medicine, Division of Nephrology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
Clin Infect Dis 43:377-80. 2006..Hypertensive vascular disease surpassed HIV-associated nephropathy as the most common renal pathological finding among the entire cohort. HIV-1 RNA level did not correlate with renal survival... - Antiretroviral therapy in the treatment of HIV-associated nephropathyMohamed G Atta
Department of Medicine, Division of Nephrology, Johns Hopkins University, 1830 East Monument Street, Baltimore, MD 21205, USA
Nephrol Dial Transplant 21:2809-13. 2006..This study was undertaken to further elucidate the potential benefit of ART in HIV-infected patients with documented HIVAN... - A proteomic analysis of human hemodialysis fluidHenrik Molina
McKusick Nathans Institute for Genetic Medicine and Department of Biological Chemistry and Oncology, The Johns Hopkins University, Baltimore, Maryland 21205, USA
Mol Cell Proteomics 4:637-50. 2005..The proteins identified in this study could serve as biomarkers in serum using more sensitive methods such as ELISA-specific antibodies... - An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopesArjun Srinivasan
Department of Hospital Epidemiology and Infection Control, Johns Hopkins Medical Institutions, Baltimore, MD, USA
N Engl J Med 348:221-7. 2003..Instrument safety and surveillance methods for bronchoscopy must be improved, and better recall procedures are needed for medical devices...